L&G Pharma Breakthrough UCITS ETF - USD Stock

ETF

Market Closed - London S.E. Other stock markets 11:35:06 2024-06-27 EDT			5-day change	1st Jan Change
779.9 ^GBX	-0.60%		+4.12%	-5.16%

2018

Duration

Period

Style

The L&G Pharma Breakthrough UCITS ETF (the 'ETF') aims to track the performance of the Solactive Pharma Breakthrough Value Index (the 'Index').

Name	Price	Change	5d. change	1st Jan change	Weight
UNITED THERAPEUTICS CORPORATION	316.2 USD	-0.88%	+2.32%	+43.78%	2.55%
SWEDISH ORPHAN BIOVITRUM AB	284.2 SEK	+1.00%	+2.82%	+6.44%	2.55%
KISSEI PHARMACEUTICAL CO., LTD.	3,245 JPY	0.00%	+2.04%	+5.02%	2.50%
MN-FOND PAO	- RUB	-	-	-	2.48%
TRICON CAPITAL GROUP	- CAD	-.--%	-	-	2.48%
JACN GROU	- AUD	-.--%	-	-	2.48%
VTE TEST SYMBOL 4	- USD	-.--%	-	-	2.48%
NOBE META	- AUD	-.--%	-	-	2.48%
GREN PROP	- EUR	-.--%	-	-	2.48%
SPONDA	- EUR	-.--%	-	-	2.48%
THE SCOTTISH SALMON	- NOK	-.--%	-	-	2.48%
CERAMICHE RICCHETTI	0.214 EUR	-.--%	-	-	2.48%
COBHAM	- GBX	-.--%	-	-	2.48%
J55 CAPITAL CORP	0.3938 CAD	-17.11%	-	-	2.48%
NEWCREST MINING LIMITED	21.1 CAD	-0.24%	-	-	2.48%
BAVARIAN NORDIC A/S	187.2 DKK	+2.38%	+19.51%	+5.47%	2.41%
BIOGEN INC.	227.1 USD	+1.19%	+0.87%	-12.07%	2.40%
EISAI CO., LTD.	6,629 JPY	+0.03%	+4.41%	-6.00%	2.38%
DAIICHI SANKYO CO., LTD.	5,506 JPY	-2.58%	+3.17%	+42.20%	2.37%
GENMAB A/S	1,778 DKK	-0.70%	-1.03%	-17.47%	2.37%

Invesco launches US climate-focused ETF with $1.6 bln in Finnish funding	12:11pm	RE
Investment manager VanEck files to list spot Solana ETF	09:06am	RE
Vanguard International Equity Index Funds - Vanguard FTSE Europe ETF Reports Earnings Results for the Half Year Ended April 30, 2024	06:05am	CI
US regulators could approve spot ether ETFs for launch by July 4, sources say	06-26	RE
US value stocks offer opportunities for bargain-hunters, BofA's Subramanian says	06-26	RE
GoodRx Launches New "Prescription Cost Tracker" to Spotlight Key Factors Driving Out-Of-Pocket Medication Costs in the U.S	06-26	CI
Cryptoverse: Trump drubs Biden in meme coins	06-25	RE
SPDR Dow Jones Industrial Average ETF Trust Reports Earnings Results for the Half Year Ended April 30, 2024	06-24	CI

In partnership with

Date	Price	Change	Volume
24-06-27	779.9	-0.60%	34
24-06-26	784.6	+0.49%	116
24-06-25	780.8	+0.06%	2,689
24-06-24	780.3	+2.53%	29,280
24-06-21	761	+1.60%	107

Other stock markets

Delayed Quote London S.E.

Last update June 27, 2024 at 11:35 am

	IE00BF0H7608
Total Expense Ratio	0.49%
Asset Class	Actions
Sector	No restriction
Size	No restriction
Currency	USD
Provider	LGIM
Underlying	Solactive Pharma Breakthrough Value NTR Index - USD

Retail investor